Vaccines (Mar 2021)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies

  • Pedro M. Folegatti,
  • Amy Flaxman,
  • Daniel Jenkin,
  • Rebecca Makinson,
  • Lucy Kingham-Page,
  • Duncan Bellamy,
  • Fernando Ramos Lopez,
  • Jonathan Sheridan,
  • Ian Poulton,
  • Jeremy Aboagye,
  • Nguyen Tran,
  • Celia Mitton,
  • Rachel Roberts,
  • Alison M. Lawrie,
  • Adrian V. S. Hill,
  • Katie J. Ewer,
  • Sarah Gilbert

DOI
https://doi.org/10.3390/vaccines9030262
Journal volume & issue
Vol. 9, no. 3
p. 262

Abstract

Read online

Heterologous prime-boost strategies are known to substantially increase immune responses in viral vectored vaccines. Here we report on safety and immunogenicity of the poxvirus Modified Vaccinia Ankara (MVA) vectored vaccine expressing four Mycobacterium avium subspecies paratuberculosis antigens as a single dose or as a booster vaccine following a simian adenovirus (ChAdOx2) prime. We demonstrate that a heterologous prime-boost schedule is well tolerated and induced T-cell immune responses.

Keywords